August 11, 2022 | Daily JAM, RUN, SGMO, Volatility |
Yesterday’s bounce on the better-than-expected July CPI inflation numbers–the annual rate dropped to 8.5% from 9.1% in June while economists surveyed by Bloomberg were expecting a drop to an 8.7% rate–looks to be fading today, August 11, but I’m going to squeeze in two more sells, Sangamo Therapeutics (SGMO) and Sunrun (RUN) for tomorrow to take advantage of this Bear Market rally. Both sells are out of my Volatility Portfolio. The high potential upside of these two picks has driven them to big gains in the Bear Market rally that began in July. That same volatility, on the downside, makes them stocks I don’t want to hold in any return of the Bear Market.
November 4, 2021 | Daily JAM, SGMO, Volatility |
Shares of Sangamo Therapeutics (SGMO) closed 19.15% higher today, November 4, on good news from multiple clinical trials at the gene therapy company.
July 9, 2019 | Daily JAM, SGMO, Stock Alerts, Volatility |
On July 5 Sangamo Therapeutics (SGMO) and partner Pfizer (PFE) announced update results of a Phase 1/2 study of Sangamo's SB-525 gene therapy for severe hemophilia A. The companies also announced that the U.S. Food & Drug Administration had granted regenerative...
April 2, 2019 | Daily JAM, SGMO, Stock Alerts |
Two big pieces of positive news popped shares of Sangamo Therapeutics (SGMO) today by 28.96% at the close. First, Sangamo announced interim data from its Hemophilia A program with Pfizer (PFE). The SB-525 gene therapy Phase 1/2 study in eight patients showed...
December 11, 2018 | Daily JAM, SGMO |
As an investor in Sangamo (SGMO) the very slow and cautious pace of regulatory action at the U.S. Food & Drug Administration is frustrating. The FDA has only slowly allowed the company to expand the number of patients enrolled in the the safety trials for its new...
December 3, 2018 | ALV, AMZN, CAT, CTRP, Daily JAM, DE, FCX, FQVLF, NVDA, SGMO, Volatility, ZNH |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
October 9, 2018 | Daily JAM, SGMO, Stock Alerts |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
September 10, 2018 | Daily JAM, SGMO, Stock Alerts |
On Monday September 10, I snuck a buy recommendation for shares of Sangamo Therapeutics (SGMO) in just before the 5 p.m. deadline for my daily e-mail update. Here's a full post on the logic for that recommendation. I'd has been a wild ride for shares of biotech...
